3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
124
Recurrence
11
Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms, Plasma Cell
5
Smoldering Multiple Myeloma
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Plasmacytoma
2
Plasmablastic Lymphoma
2
Myelodysplastic Syndromes
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Amyloidosis
2
Acute Kidney Injury
2
Triple Negative Breast Neoplasms
1
Proteostasis Deficiencies
1
Primary Myelofibrosis
1
Paraproteinemias
1
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
1
Neoplasm, Residual
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cyclophosphamide
3
Dexamethasone
2
Bortezomib
2
veliparib
1
pembrolizumab
1
isatuximab
1
gallium 68 PSMA-11
1
Whole-Body Irradiation
1
Taxes
1
Standard of Care
1
Pluvicto
1
Paclitaxel
1
Kidney Transplantation
1
Health Information Exchange
1
Eplerenone
1
Carboplatin
1
Calcium Dobesilate
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
daratumumab
×
1 year
×
Clear all
No trials found.